{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:00:52Z","timestamp":1791608452551,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301169"],"award-info":[{"award-number":["32301169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22076132"],"award-info":[{"award-number":["22076132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Natural Science Foundation of Anhui Province","award":["2308085QH281"],"award-info":[{"award-number":["2308085QH281"]}]},{"name":"Key Project for the Cultivation of Outstanding Young Teachers of Anhui Province","award":["YQZD2025019"],"award-info":[{"award-number":["YQZD2025019"]}]},{"name":"the Key Scientific Research Project of Colleges and Universities of Anhui Province of China","award":["2022AH050683"],"award-info":[{"award-number":["2022AH050683"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03936-4","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:24:40Z","timestamp":1767075880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["131I\/MTX-loaded engineered outer membrane vesicles for sequentially coordinated radio-metabolic-immunotherapy of glioma"],"prefix":"10.1186","volume":"24","author":[{"given":"Maolin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"3936_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329:574\u201387.","journal-title":"JAMA"},{"key":"3936_CR2","first-page":"381","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin. 2021;71:381\u2013406.","journal-title":"CA Cancer J Clin"},{"key":"3936_CR3","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1038\/s41467-020-18569-4","volume":"11","author":"A De Boeck","year":"2020","unstructured":"De Boeck A, Ahn BY, D\u2019Mello C, Lun X, Menon SV, Alshehri MM, et al. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression. Nat Commun. 2020;11:4997.","journal-title":"Nat Commun"},{"key":"3936_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular States, Plasticity, and genetics for glioblastoma. Cell. 2019;178:835\u201349.","journal-title":"Cell"},{"key":"3936_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41568-021-00397-3","volume":"21","author":"BM Andersen","year":"2021","unstructured":"Andersen BM, Faust Akl C, Wheeler MA, Chiocca EA, Reardon DA, Quintana FJ. Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat Rev Cancer. 2021;21:786\u2013802.","journal-title":"Nat Rev Cancer"},{"key":"3936_CR6","doi-asserted-by":"publisher","first-page":"e2321611121","DOI":"10.1073\/pnas.2321611121","volume":"121","author":"R Wu","year":"2024","unstructured":"Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X, et al. NSUN5\/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. Proc Natl Acad Sci USA. 2024;121:e2321611121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3936_CR7","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","volume":"28","author":"MA Qazi","year":"2017","unstructured":"Qazi MA, Vora P, Venugopal C, Sidhu SS, Moffat J, Swanton C, et al. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Ann Oncol. 2017;28:1448\u201356.","journal-title":"Ann Oncol"},{"key":"3936_CR8","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the Art and future directions. CA Cancer J Clin. 2020;70:299\u2013312.","journal-title":"CA Cancer J Clin"},{"key":"3936_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","volume":"499","author":"T Jiang","year":"2021","unstructured":"Jiang T, Nam D-H, Ram Z, Poon W-s, Wang J, Boldbaatar D, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021;499:60\u201372.","journal-title":"Cancer Lett"},{"key":"3936_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s43018-023-00619-7","volume":"4","author":"DA Jaffray","year":"2023","unstructured":"Jaffray DA, Knaul F, Baumann M, Gospodarowicz M. Harnessing progress in radiotherapy for global cancer control. Nat Cancer. 2023;4:1228\u201338.","journal-title":"Nat Cancer"},{"key":"3936_CR11","doi-asserted-by":"publisher","first-page":"216557","DOI":"10.1016\/j.ccr.2025.216557","volume":"533","author":"L Wang","year":"2025","unstructured":"Wang L, He Q, Man J, Gao Y, Zhou G, Si H, et al. Novel bio-carriers for radionuclide delivery in cancer radiotherapy. Coord Chem Rev. 2025;533:216557.","journal-title":"Coord Chem Rev"},{"key":"3936_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41571-022-00709-y","volume":"20","author":"JM Price","year":"2023","unstructured":"Price JM, Prabhakaran A, West CML. Predicting tumour radiosensitivity to deliver precision radiotherapy. Nat Rev Clin Oncol. 2023;20:83\u201398.","journal-title":"Nat Rev Clin Oncol"},{"key":"3936_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","volume":"12","author":"D Schaue","year":"2015","unstructured":"Schaue D, McBride WH. Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015;12:527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"3936_CR14","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.xcrm.2023.101151","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Hu J, Ji K, Jiang S, Dong Y, Sun L, et al. CD39 Inhibition and VISTA Blockade May overcome radiotherapy resistance by targeting exhausted CD8\u2009+\u2009T cells and immunosuppressive myeloid cells. Cell Rep Med. 2023;4:101151.","journal-title":"Cell Rep Med"},{"key":"3936_CR15","doi-asserted-by":"publisher","first-page":"2312197","DOI":"10.1002\/adfm.202312197","volume":"34","author":"Y Xie","year":"2024","unstructured":"Xie Y, Zhang C, Zhao Y, Li T, Shen W, Hu L, et al. Simultaneous modulation of hypoxia and metabolism in glioblastoma for enhanced Radio-Immunotherapy. Adv Funct Mater. 2024;34:2312197.","journal-title":"Adv Funct Mater"},{"key":"3936_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2024.10.010","volume":"376","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Dong X, Zhang Y, Chen Z, Zhou G, Chen N, et al. Biomaterials to regulate tumor extracellular matrix in immunotherapy. J Control Release. 2024;376:149\u201366.","journal-title":"J Control Release"},{"key":"3936_CR17","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. 2022;185:2184\u201399.","journal-title":"Cell"},{"key":"3936_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","volume":"20","author":"JH Sampson","year":"2020","unstructured":"Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer. 2020;20:12\u201325.","journal-title":"Nat Rev Cancer"},{"key":"3936_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16:145\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"3936_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.canlet.2019.11.013","volume":"470","author":"AD Robinson","year":"2020","unstructured":"Robinson AD, Eich M-L, Varambally S. Dysregulation of de Novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities. Cancer Lett. 2020;470:134\u201340.","journal-title":"Cancer Lett"},{"key":"3936_CR21","doi-asserted-by":"publisher","first-page":"eadq1724","DOI":"10.1126\/sciadv.adq1724","volume":"11","author":"S-Y Kim","year":"2025","unstructured":"Kim S-Y, de Weert TAE, Vermeulen M, Ringnalda F, Kester L, Zsiros J, et al. Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer. Sci Adv. 2025;11:eadq1724.","journal-title":"Sci Adv"},{"key":"3936_CR22","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.1021\/acsnano.1c02283","volume":"15","author":"D Manoharan","year":"2021","unstructured":"Manoharan D, Chang L-C, Wang L-C, Shan Y-S, Lin F-C, Wu L-C, et al. Synchronization of nanoparticle sensitization and radiosensitizing chemotherapy through cell cycle arrest achieving ultralow X-ray dose delivery to pancreatic tumors. ACS Nano. 2021;15:9084\u2013100.","journal-title":"ACS Nano"},{"key":"3936_CR23","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.2967\/jnumed.108.051771","volume":"49","author":"DL Costantini","year":"2008","unstructured":"Costantini DL, Bateman K, McLarty K, Vallis KA, Reilly RM. Trastuzumab-Resistant breast cancer cells remain sensitive to the Auger Electron\u2013Emitting radiotherapeutic agent 111In-NLS-Trastuzumab and are radiosensitized by methotrexate. J Nucl Med. 2008;49:1498\u2013505.","journal-title":"J Nucl Med"},{"key":"3936_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2967\/jnumed.109.069716","volume":"51","author":"DL Costantini","year":"2010","unstructured":"Costantini DL, Villani DF, Vallis KA, Reilly RM. Methotrexate, Paclitaxel, and doxorubicin radiosensitize HER2-Amplified human breast cancer cells to the Auger Electron\u2013Emitting radiotherapeutic agent 111In-NLS-Trastuzumab. J Nucl Med. 2010;51:477\u201383.","journal-title":"J Nucl Med"},{"key":"3936_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41551-020-0583-0","volume":"4","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhang H, Zhou N, Xu P, Wang J, Gao Y, et al. Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma. Nat Biomed Eng. 2020;4:743\u201353.","journal-title":"Nat Biomed Eng"},{"key":"3936_CR26","doi-asserted-by":"publisher","first-page":"2109213","DOI":"10.1002\/adma.202109213","volume":"34","author":"C-Y Dong","year":"2022","unstructured":"Dong C-Y, Huang Q-X, Cheng H, Zheng D-W, Hong S, Yan Y, et al. Neisseria meningitidis Opca Protein\/MnO2 hybrid nanoparticles for overcoming the Blood\u2013Brain barrier to treat glioblastoma. Adv Mater. 2022;34:2109213.","journal-title":"Adv Mater"},{"key":"3936_CR27","doi-asserted-by":"publisher","first-page":"2201401","DOI":"10.1002\/smtd.202201401","volume":"7","author":"T Liu","year":"2023","unstructured":"Liu T, Pei P, Shen W, Hu L, Yang K. Radiation-Induced Immunogenic cell death for cancer radioimmunotherapy. Small Methods. 2023;7:2201401.","journal-title":"Small Methods"},{"key":"3936_CR28","doi-asserted-by":"crossref","unstructured":"Chen Z, He Q, Qian R, Cai J, Wang Z, Zhou X et al. Reengineering the tumor oxygen microenvironment in radiotherapy to enhance T-cell function for radio-immunotherapy. Adv Funct Mater. 2025;35:2502807.","DOI":"10.1002\/adfm.202502807"},{"key":"3936_CR29","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1002\/agt2.484","volume":"5","author":"P Pei","year":"2024","unstructured":"Pei P, Wang Y, Shen W, He Q, Han X, Zhang C, et al. Oxygen-driven Cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy. Aggregate. 2024;5:e484.","journal-title":"Aggregate"},{"key":"3936_CR30","doi-asserted-by":"publisher","first-page":"e005011","DOI":"10.1136\/jitc-2022-005011","volume":"11","author":"ME Rodriguez-Ruiz","year":"2023","unstructured":"Rodriguez-Ruiz ME, Serrano-Mendioroz I, Garate-Soraluze E, S\u00e1nchez-Mateos P, Barrio-Alonso C, Rodr\u00edguez L\u00f3pez I, et al. Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control. J Immunother Cancer. 2023;11:e005011.","journal-title":"J Immunother Cancer"},{"key":"3936_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Neidert N, Will P, Joseph K, Maier JP, K\u00fcckelhaus J, et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022;13:925.","journal-title":"Nat Commun"},{"key":"3936_CR32","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","volume":"76","author":"AL Chang","year":"2016","unstructured":"Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, et al. CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and Myeloid-Derived suppressor cells. Cancer Res. 2016;76:5671\u201382.","journal-title":"Cancer Res"},{"key":"3936_CR33","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41591-025-03530-z","volume":"31","author":"S Tagore","year":"2025","unstructured":"Tagore S, Caprio L, Amin AD, Bestak K, Luthria K, D\u2019Souza E, et al. Single-cell and Spatial genomic landscape of non-small cell lung cancer brain metastases. Nat Med. 2025;31:1351\u201363.","journal-title":"Nat Med"},{"key":"3936_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/neuonc\/noae219","volume":"27","author":"LD Schreurs","year":"2025","unstructured":"Schreurs LD, vom Stein AF, J\u00fcnger ST, Timmer M, Noh K-W, Buettner R, et al. The immune landscape in brain metastasis. Neuro Oncol. 2025;27:50\u201362.","journal-title":"Neuro Oncol"},{"key":"3936_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-025-08997-x","volume":"643","author":"C Faust Akl","year":"2025","unstructured":"Faust Akl C, Andersen BM, Li Z, Giovannoni F, Diebold M, Sanmarco LM, et al. Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity. Nature. 2025;643:219\u201329.","journal-title":"Nature"},{"key":"3936_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41:573\u201380.","journal-title":"Cancer Cell"},{"key":"3936_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-051122-110348","volume":"19","author":"MA Jayaram","year":"2024","unstructured":"Jayaram MA, Phillips JJ. Role of the microenvironment in glioma pathogenesis. Annu Rev Pathol. 2024;19:181\u2013201.","journal-title":"Annu Rev Pathol"},{"key":"3936_CR38","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, et al. STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nat Commun. 2023;14:1610.","journal-title":"Nat Commun"},{"key":"3936_CR39","doi-asserted-by":"publisher","first-page":"e009852","DOI":"10.1136\/jitc-2024-009852","volume":"13","author":"E Garate-Soraluze","year":"2025","unstructured":"Garate-Soraluze E, Serrano-Mendioroz I, Fern\u00e1ndez-Rubio L, De Andrea CE, Barrio-Alonso C, Herrero CP, et al. 4-1BB agonist targeted to fibroblast activation protein \u03b1 synergizes with radiotherapy to treat murine breast tumor models. J Immunother Cancer. 2025;13:e009852.","journal-title":"J Immunother Cancer"},{"key":"3936_CR40","doi-asserted-by":"publisher","first-page":"2401615","DOI":"10.1002\/adhm.202401615","volume":"13","author":"Z Bai","year":"2024","unstructured":"Bai Z, Wang X, Liang T, Xu G, Cai J, Xu W, et al. Harnessing bacterial membrane components for tumor vaccines: strategies and perspectives. Adv Healthc Mater. 2024;13:2401615.","journal-title":"Adv Healthc Mater"},{"key":"3936_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41565-023-01553-6","volume":"19","author":"G Liu","year":"2024","unstructured":"Liu G, Ma N, Cheng K, Feng Q, Ma X, Yue Y, et al. Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity. Nat Nanotechnol. 2024;19:387\u201398.","journal-title":"Nat Nanotechnol"},{"key":"3936_CR42","doi-asserted-by":"publisher","first-page":"114321","DOI":"10.1016\/j.addr.2022.114321","volume":"186","author":"Q Long","year":"2022","unstructured":"Long Q, Zheng P, Zheng X, Li W, Hua L, Yang Z, et al. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy. Adv Drug Del Rev. 2022;186:114321.","journal-title":"Adv Drug Del Rev"},{"key":"3936_CR43","doi-asserted-by":"publisher","first-page":"2405304","DOI":"10.1002\/adfm.202405304","volume":"34","author":"L Fu","year":"2024","unstructured":"Fu L, He Q, Lu X, Hu L, Qian H, Pei P. Surface engineering on bacteria for tumor immunotherapy: strategies and perspectives. Adv Funct Mater. 2024;34:2405304.","journal-title":"Adv Funct Mater"},{"key":"3936_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2022.04.029","volume":"346","author":"Z Qi","year":"2022","unstructured":"Qi Z, Pei P, Zhang Y, Chen H, Yang S, Liu T, et al. 131I-\u03b1PD-L1 immobilized by bacterial cellulose for enhanced radio-immunotherapy of cancer. J Control Release. 2022;346:240\u20139.","journal-title":"J Control Release"},{"key":"3936_CR45","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1016\/j.apsb.2022.10.013","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Huang R, Jiang Y, Shen W, Pei H, Wang G, et al. The role of bacteria and its derived biomaterials in cancer radiotherapy. Acta Pharm Sin B. 2023;13:4149\u201371.","journal-title":"Acta Pharm Sin B"},{"key":"3936_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41579-023-00875-5","volume":"21","author":"M Toyofuku","year":"2023","unstructured":"Toyofuku M, Schild S, Kaparakis-Liaskos M, Eberl L. Composition and functions of bacterial membrane vesicles. Nat Rev Microbiol. 2023;21:415\u201330.","journal-title":"Nat Rev Microbiol"},{"key":"3936_CR47","doi-asserted-by":"publisher","first-page":"2106307","DOI":"10.1002\/adma.202106307","volume":"34","author":"J Pan","year":"2022","unstructured":"Pan J, Li X, Shao B, Xu F, Huang X, Guo X, et al. Self-blockade of PD-L1 with bacteria-derived outer-membrane vesicle for enhanced cancer immunotherapy. Adv Mater. 2022;34:2106307.","journal-title":"Adv Mater"},{"key":"3936_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1021\/acsnano.3c05714","volume":"18","author":"X Chen","year":"2024","unstructured":"Chen X, Li P, Luo B, Song C, Wu M, Yao Y, et al. Surface mineralization of engineered bacterial outer membrane vesicles to enhance tumor photothermal\/immunotherapy. ACS Nano. 2024;18:1357\u201370.","journal-title":"ACS Nano"},{"key":"3936_CR49","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.1021\/acs.nanolett.1c02482","volume":"21","author":"M-Z Zou","year":"2021","unstructured":"Zou M-Z, Li Z-H, Bai X-F, Liu C-J, Zhang X-Z. Hybrid vesicles based on autologous tumor cell membrane and bacterial outer membrane to enhance innate immune response and personalized tumor immunotherapy. Nano Lett. 2021;21:8609\u201318.","journal-title":"Nano Lett"},{"key":"3936_CR50","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jconrel.2023.08.002","volume":"361","author":"X Jiang","year":"2023","unstructured":"Jiang X, Wu L, Zhang M, Zhang T, Chen C, Wu Y, et al. Biomembrane nanostructures: multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery. J Control Release. 2023;361:510\u201333.","journal-title":"J Control Release"},{"key":"3936_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.apsb.2022.09.016","volume":"13","author":"Z Mi","year":"2023","unstructured":"Mi Z, Yao Q, Qi Y, Zheng J, Liu J, Liu Z, et al. Salmonella-mediated blood\u2013brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo\/bacterial glioma therapy. Acta Pharm Sin B. 2023;13:819\u201333.","journal-title":"Acta Pharm Sin B"},{"key":"3936_CR52","first-page":"169","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu H, Zhang Q, Wang S, Weng W, Jing Y, Su J. Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives. Bioact Mater. 2022;14:169\u201381.","journal-title":"Bioact Mater"},{"key":"3936_CR53","doi-asserted-by":"publisher","first-page":"16698","DOI":"10.1021\/acsnano.0c03776","volume":"14","author":"Y Li","year":"2020","unstructured":"Li Y, Zhao R, Cheng K, Zhang K, Wang Y, Zhang Y, et al. Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint Inhibition. ACS Nano. 2020;14:16698\u2013711.","journal-title":"ACS Nano"},{"key":"3936_CR54","first-page":"548","volume":"20","author":"Y Li","year":"2023","unstructured":"Li Y, Wu J, Qiu X, Dong S, He J, Liu J, et al. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic\/chemo-\/immunotherapy. Bioact Mater. 2023;20:548\u201360.","journal-title":"Bioact Mater"},{"key":"3936_CR55","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/s41467-021-22308-8","volume":"12","author":"K Cheng","year":"2021","unstructured":"Cheng K, Zhao R, Li Y, Qi Y, Wang Y, Zhang Y, et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat Commun. 2021;12:2041.","journal-title":"Nat Commun"},{"key":"3936_CR56","doi-asserted-by":"publisher","first-page":"e2403460121","DOI":"10.1073\/pnas.2403460121","volume":"121","author":"S Tang","year":"2024","unstructured":"Tang S, Tang D, Zhou H, Li Y, Zhou D, Peng X, et al. Bacterial outer membrane vesicle nanorobot. Proc Natl Acad Sci USA. 2024;121:e2403460121.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03936-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03936-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03936-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:03:10Z","timestamp":1768924990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03936-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3936"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03936-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed following the protocols evaluated and approved by Soochow University, China (Ethics Approval Number: 202405A0868) and the experiments were performed in the SPF laboratory.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}